DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Cohen H, Hunt BJ, Efthymiou M. et al.
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.
Lancet Haematol 2016;
3: e426-e436
Access:
We do not assume any responsibility for the contents of the web pages of other providers.